0001615774-15-001930.txt : 20150831 0001615774-15-001930.hdr.sgml : 20150831 20150728172546 ACCESSION NUMBER: 0001615774-15-001930 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intec Pharma Ltd. CENTRAL INDEX KEY: 0001638381 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 BUSINESS PHONE: 97225864657 MAIL ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 CORRESP 1 filename1.htm

Intec Pharma Ltd.

12 Hartom Street

Har Hotzvim, Jerusalem 777512, Israel

July 28, 2015

VIA EDGAR SUBMISSION

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Re:

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Intec Pharma Ltd.
Registration Statement on Form F-1

File No. 333-204836

Ladies and Gentlemen:

Intec Pharma Ltd. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement on Form F-1 (the “Registration Statement”) so that the Registration Statement will become effective at 4:30 p.m. (New York Time) on Thursday, July 30, 2015, or as soon thereafter as practicable.

The Company acknowledges that:

•

should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

•

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

•

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please provide a copy of the Commission’s order declaring the Registration Statement effective to the undersigned at 12 Hartom Street, Har Hotzvim, Jerusalem 777512, Israel.

	Very truly yours,

	INTEC PHARMA LTD.

	/s/ Zeev Weiss
	Zeev Weiss
	Chief Executive Officer